TEACHERS ADVISORS, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 356 filers reported holding NEKTAR THERAPEUTICS in Q1 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2019$18,376,000
+24.2%
546,897
+21.5%
0.02%
+4.8%
Q4 2018$14,794,000
-72.1%
450,084
-48.2%
0.02%
-34.4%
Q3 2018$53,012,000
+139.1%
869,604
+91.5%
0.03%
+14.3%
Q2 2018$22,175,000
-75.1%
454,136
-45.7%
0.03%
-75.7%
Q1 2018$88,946,000
+60.1%
837,064
-10.0%
0.12%
+62.0%
Q4 2017$55,565,000
+243.3%
930,424
+38.0%
0.07%
+222.7%
Q3 2017$16,184,000
+20.6%
674,346
-1.8%
0.02%
+15.8%
Q2 2017$13,423,000
-13.8%
686,586
+3.5%
0.02%
-17.4%
Q1 2017$15,568,000
+289.9%
663,324
+103.8%
0.02%
+283.3%
Q4 2016$3,993,000
-16.4%
325,456
+17.1%
0.01%
-25.0%
Q3 2016$4,775,000
+10.9%
277,964
-8.1%
0.01%0.0%
Q2 2016$4,306,000
+8.0%
302,617
+4.3%
0.01%
+14.3%
Q1 2016$3,988,000
-18.3%
290,056
+0.1%
0.01%
-22.2%
Q4 2015$4,880,000
+55.0%
289,641
+0.8%
0.01%
+50.0%
Q3 2015$3,148,000
-12.2%
287,240
+0.2%
0.01%
-14.3%
Q2 2015$3,586,000
+17.2%
286,680
+3.0%
0.01%
+16.7%
Q1 2015$3,061,000
-26.9%
278,253
+3.0%
0.01%
-25.0%
Q4 2014$4,187,000
+28.6%
270,141
+0.1%
0.01%
+14.3%
Q3 2014$3,257,000
-1.0%
269,819
+5.2%
0.01%0.0%
Q2 2014$3,289,000
+7.9%
256,519
+2.0%
0.01%0.0%
Q1 2014$3,048,000
+14.9%
251,494
+7.6%
0.01%
+16.7%
Q4 2013$2,653,000
+12.5%
233,704
+3.6%
0.01%0.0%
Q3 2013$2,358,000
-2.4%
225,634
+7.9%
0.01%0.0%
Q2 2013$2,415,000209,1210.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2019
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 508,000$6,132,0001.80%
Bodri Capital Management, LLC 250,000$3,018,0001.46%
Granahan Investment Management 3,442,980$41,557,0001.28%
TIRSCHWELL & LOEWY INC 603,441$7,284,0001.22%
NEA Management Company, LLC 1,825,600$22,035,0001.12%
Cormorant Asset Management, LP 450,000$5,432,0001.12%
HARVEY CAPITAL MANAGEMENT INC 221,750$2,676,0001.05%
Cheyne Capital Management (UK) LLP 229,577$2,772,0000.99%
Artal Group S.A. 1,650,000$19,916,0000.73%
FIC CAPITAL INC 147,293$1,778,0000.71%
View complete list of NEKTAR THERAPEUTICS shareholders